PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

CEO

ISIN

CA74143C1068

WKN

000A41QAA

Listings

0 Comments

Share your thoughts

FAQ

What is PreveCeutical Medical stock price today?▼

The current price of 18H0.F is €0.01 EUR — it has increased by +0% in the past 24 hours. Watch PreveCeutical Medical stock price performance more closely on the chart.

What is PreveCeutical Medical stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange PreveCeutical Medical stocks are traded under the ticker 18H0.F.

What is PreveCeutical Medical revenue for the last year?▼

PreveCeutical Medical revenue for the last year amounts to 0 EUR.

What is PreveCeutical Medical net income for the last year?▼

18H0.F net income for the last year is -793,945.14 EUR.

When did PreveCeutical Medical complete a stock split?▼

PreveCeutical Medical has not had any recent stock splits.